Taiwan - Delayed Quote TWD

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW)

29.40
0.00
(0.00%)
At close: May 9 at 1:30:25 PM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,347,375
1,347,375
2,086,441
2,117,144
1,934,702
Cost of Revenue
953,057
953,057
1,329,133
1,155,387
985,314
Gross Profit
394,318
394,318
757,308
961,757
949,388
Operating Expense
387,976
387,976
476,499
516,570
492,568
Operating Income
6,342
6,342
280,809
445,187
456,820
Net Non Operating Interest Income Expense
-16,926
-16,926
-12,168
-5,205
-3,140
Pretax Income
57,222
57,222
333,487
583,305
497,613
Tax Provision
4,190
4,190
68,578
117,165
96,563
Net Income Common Stockholders
53,032
53,032
264,909
465,865
400,778
Diluted NI Available to Com Stockholders
53,032
53,032
264,909
465,865
400,778
Basic EPS
0.95
--
3.42
6.01
5.17
Diluted EPS
0.94
--
3.39
5.93
5.12
Basic Average Shares
55,823.16
--
77,458.77
77,560
77,560
Diluted Average Shares
56,417.02
--
78,144.25
78,500
78,318
Total Expenses
1,341,033
1,341,033
1,805,632
1,671,957
1,477,882
Net Income from Continuing & Discontinued Operation
53,032
53,032
264,909
465,865
400,778
Normalized Income
53,032
53,032
264,909
451,204.85
415,563.11
Interest Income
4,359
4,359
7,271
4,507
181
Interest Expense
21,285
21,285
19,439
9,712
3,321
Net Interest Income
-16,926
-16,926
-12,168
-5,205
-3,140
EBIT
78,507
78,507
352,926
593,017
500,934
EBITDA
277,663
277,663
545,931
762,066
632,927
Reconciled Cost of Revenue
953,057
953,057
1,329,133
1,155,387
985,314
Reconciled Depreciation
199,156
199,156
193,005
169,049
131,993
Net Income from Continuing Operation Net Minority Interest
53,032
53,032
264,909
465,865
400,778
Total Unusual Items Excluding Goodwill
0
--
0
18,345
-18,345
Total Unusual Items
0
--
0
18,345
-18,345
Normalized EBITDA
277,663
277,663
545,931
743,721
651,272
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
3,684.85
-3,559.89
12/31/2021 - 12/20/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

1734.TW Sinphar Pharmaceutical Co.,Ltd.
31.95
+0.16%
 
1760.TW Panion & Bf Biotech Inc.
70.00
+0.14%
 
3164.TW GenMont Biotech Incorporation
20.20
+0.50%
 
1733.TW Apex Biotechnology Corp.
30.10
-0.82%
 
4133.TW Abnova (Taiwan) Corporation
28.60
-0.87%
 
6838.TW Formosa Pharmaceuticals, Inc.
24.70
-1.20%
 
4142.TW Adimmune Corporation
18.50
0.00%
 
4130.TWO Genovate Biotechnology Co., Ltd.
20.95
-0.24%
 
4167.TWO Savior Lifetec Corporation
20.45
+2.51%
 
6885.TW BRIM Biotechnology, Inc.
22.35
+0.68%